Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies

Exclusion Criteria

• •Pregnant or Breastfeeding patient
• •Patient in age to procreate without an efficient contraceptive method
• •Patient with previous experience of allergic or irritative contact dermatitis to components of the studied product
• •Patient with dermatologic conditions that cannot permit the study of skin toxicity of anti-EGFR
• •Patients under radiotherapy 8 days prior the inclusion date
• •Patient under immunotherapy 8 days prior the inclusion date
• •Patient with local or systemic antibiotic treatment for acne 8 days prior the inclusion date
• •Patient with antihistamines treatment 8 days prior the inclusion date
• •Patients taking NSAIDs or corticoids as chronic medication or that took NSAIDs or corticoids 5 days prior the inclusion date
• •Participation to another interventional study
• •Patient with an altered ECOG (Eastern Cooperative Oncology Group) state ( \>2)
• •Patient deprived of liberty or subjected to guardianship
• •Impossibility to track and follow patient for geographical, social or psychiatric reasons.